Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Dr. Reddy's Laboratories Ltd.
Press Release Sep 17 2020
Published Sep 17 2020
5 min read

Press Release Sep 17 2020

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 17, 2020, titled "Dr. Reddy's Laboratories announces settlement ofU.S. Revlimid�� (lenalidomide) Capsules patent litigation with Celgene, a Bristol MyersSquibb Company".

View Attachment